Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ENZ | Common Stock, $0.01 Par Value | 19.4K | May 26, 2023 | 401k |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENZ | Stock Option (to acquire Common Stock) | Award | $0 | +25K | $0.00 | 25K | May 26, 2023 | Common Stock | 25K | $2.29 | Direct | F1 |
Id | Content |
---|---|
F1 | The Reporting Person was granted 25,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on May 26, 2024. |